Genetic Analyses of the Chimeric CYP11B1 / CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism
Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene dupl...
Saved in:
Published in | Journal of Korean medical science Vol. 25; no. 9; pp. 1379 - 1383 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Academy of Medical Sciences
01.09.2010
대한의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1011-8934 1598-6357 1598-6357 |
DOI | 10.3346/jkms.2010.25.9.1379 |
Cover
Loading…
Abstract | Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2. |
---|---|
AbstractList | Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2.Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2. Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2. Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11β-hydroxylase ( CYP11B1 ) and aldosterone synthase ( CYP11B2 ) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1 / CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2 . Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2)genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2. KCI Citation Count: 2 |
Author | Jo, Young Suk Kim, Seul Young Lee, Ju Hee Lee, Yun Hyeong Jang, Hye Won Lee, Ihn Suk Kim, Min Kyeong |
AuthorAffiliation | 2 Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea 1 Division of Endocrinology, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea |
AuthorAffiliation_xml | – name: 1 Division of Endocrinology, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea – name: 2 Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea |
Author_xml | – sequence: 1 givenname: Ihn Suk surname: Lee fullname: Lee, Ihn Suk organization: Division of Endocrinology, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea – sequence: 2 givenname: Seul Young surname: Kim fullname: Kim, Seul Young organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea – sequence: 3 givenname: Hye Won surname: Jang fullname: Jang, Hye Won organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea – sequence: 4 givenname: Min Kyeong surname: Kim fullname: Kim, Min Kyeong organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea – sequence: 5 givenname: Ju Hee surname: Lee fullname: Lee, Ju Hee organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea – sequence: 6 givenname: Yun Hyeong surname: Lee fullname: Lee, Yun Hyeong organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea – sequence: 7 givenname: Young Suk surname: Jo fullname: Jo, Young Suk organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20808686$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001469820$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kUtvEzEUhS1URB_wC5CQd7CZ1K-ZjDdIIaKhohKoKgtWlse-Q9x47NaeUOXf42lCBSxY-Vr3O-de-5yioxADIPSakhnnojm_3Qx5xki5snomZ5TP5TN0QmvZVg2v50elJpRWreTiGJ3mfEsIq2vGX6BjRlrSNm1zgh5WEGB0Bi-C9rsMGccej2vAy7UbIJXG8vtXSj9QfH6oGJ4k2AWs8eeYQAd8oQfnd_jBjWu88lsTTUzFMzpbXcMA1unOA154G_MIKQaXh5foea99hleH8wx9u_h4s_xUXX1ZXS4XV5Xhko1VJ5q50La1PZSHNZq3neSko1TarrZNo60kwtBeCAG90VxaZhmQjsmu5RI0P0Pv9r4h9WpjnIraPZ4_otoktbi-uVT1XJCWF_T9Hr3bdmVpA2FM2qu75Aaddo_CvzvBrYvNT8UkK3_fFoO3B4MU77eQRzW4bMB7HSBus5rXXErZEFHIN3-OeprxO5cC8D1gUsw5Qf-EUKKm9NWUvprSV6xWUk3pF5X8R2XcqEcXp32d_6_2F0DDtiY |
CitedBy_id | crossref_primary_10_3389_fped_2020_588911 crossref_primary_10_3803_EnM_2012_27_4_329 crossref_primary_10_1097_MED_0b013e3283469444 crossref_primary_10_1210_clinem_dgae127 crossref_primary_10_1210_clinem_dgae523 crossref_primary_10_1093_ajh_hpaf005 crossref_primary_10_1097_MED_0b013e3283473d73 crossref_primary_10_1155_2018_8647026 crossref_primary_10_3389_fped_2019_00263 |
Cites_doi | 10.1161/01.HYP.38.3.688 10.1067/mpd.2001.112648 10.1006/bbrc.1995.1225 10.1590/S0004-27302004000500014 10.1038/355262a0 10.1016/S0960-0760(01)00097-8 10.1016/0039-128X(94)00010-A 10.1210/jcem.85.9.6834 10.1046/j.1440-1681.2001.03574.x 10.1038/sj.jhh.1001821 10.1210/jcem.84.12.6256 10.1038/sj.jhh.1001152 |
ContentType | Journal Article |
Copyright | 2010 The Korean Academy of Medical Sciences. 2010 |
Copyright_xml | – notice: 2010 The Korean Academy of Medical Sciences. 2010 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.3346/jkms.2010.25.9.1379 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1598-6357 |
EndPage | 1383 |
ExternalDocumentID | oai_kci_go_kr_ARTI_574083 PMC2923798 20808686 10_3346_jkms_2010_25_9_1379 |
Genre | Journal Article Case Reports |
GeographicLocations | Republic of Korea |
GeographicLocations_xml | – name: Republic of Korea |
GroupedDBID | --- 29K 2WC 3O- 5-W 53G 5GY 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 D-I DIK DU5 E3Z EBS EF. EJD F5P FRP GROUPED_DOAJ GX1 HYE KQ8 M48 O5R O5S OK1 OVT PGMZT RNS RPM TR2 W2D XSB CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c392t-b4674ad8dfe1596a38b930b119db5d66ad904c1f444efca39d2d2e0b29b839ea3 |
IEDL.DBID | M48 |
ISSN | 1011-8934 1598-6357 |
IngestDate | Sun Mar 09 07:53:53 EDT 2025 Thu Aug 21 14:06:20 EDT 2025 Fri Jul 11 02:57:01 EDT 2025 Thu Apr 03 07:00:13 EDT 2025 Tue Jul 01 01:44:44 EDT 2025 Thu Apr 24 23:01:26 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Hyperaldosteronism Aldosterone Synthase Steroid 11-beta-Hydroxylase |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c392t-b4674ad8dfe1596a38b930b119db5d66ad904c1f444efca39d2d2e0b29b839ea3 |
Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 Ihn Suk Lee and Seul Young Kim contributed equally to the work. http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120100250091379 G704-000345.2010.25.9.021 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2010.25.9.1379 |
PMID | 20808686 |
PQID | 753999604 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_574083 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2923798 proquest_miscellaneous_753999604 pubmed_primary_20808686 crossref_primary_10_3346_jkms_2010_25_9_1379 crossref_citationtrail_10_3346_jkms_2010_25_9_1379 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-09-01 |
PublicationDateYYYYMMDD | 2010-09-01 |
PublicationDate_xml | – month: 09 year: 2010 text: 2010-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of Korean medical science |
PublicationTitleAlternate | J Korean Med Sci |
PublicationYear | 2010 |
Publisher | The Korean Academy of Medical Sciences 대한의학회 |
Publisher_xml | – name: The Korean Academy of Medical Sciences – name: 대한의학회 |
References | Litchfield (10.3346/jkms.2010.25.9.1379_ref10) 1997; 82 Stowasser (10.3346/jkms.2010.25.9.1379_ref13) 2000; 85 Jonsson (10.3346/jkms.2010.25.9.1379_ref5) 1995; 207 Lifton (10.3346/jkms.2010.25.9.1379_ref2) 1992; 355 Mosso (10.3346/jkms.2010.25.9.1379_ref3) 2001; 38 Pizzolo (10.3346/jkms.2010.25.9.1379_ref7) 2005; 19 Gates (10.3346/jkms.2010.25.9.1379_ref9) 2001; 15 Stowasser (10.3346/jkms.2010.25.9.1379_ref12) 2001; 28 Dluhy (10.3346/jkms.2010.25.9.1379_ref17) 2001; 138 Dluhy (10.3346/jkms.2010.25.9.1379_ref14) 1995; 60 Stowasser (10.3346/jkms.2010.25.9.1379_ref15) 2000; 85 McMahon (10.3346/jkms.2010.25.9.1379_ref8) 2004; 48 Stowasser (10.3346/jkms.2010.25.9.1379_ref11) 2001; 78 Dluhy (10.3346/jkms.2010.25.9.1379_ref16) 1999; 84 Fardella (10.3346/jkms.2010.25.9.1379_ref4) 2000; 85 Loh (10.3346/jkms.2010.25.9.1379_ref6) 2000; 85 Sutherland (10.3346/jkms.2010.25.9.1379_ref1) 1966; 95 15660117 - J Hum Hypertens. 2005 Apr;19(4):325-7 11317201 - J Hum Hypertens. 2001 Mar;15(3):173-6 4288576 - Can Med Assoc J. 1966 Nov 26;95(22):1109-19 15761539 - Arq Bras Endocrinol Metabol. 2004 Oct;48(5):682-6 7864844 - Biochem Biophys Res Commun. 1995 Feb 15;207(2):565-71 1731223 - Nature. 1992 Jan 16;355(6357):262-5 11343049 - J Pediatr. 2001 May;138(5):715-20 11903322 - Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1087-90 10999827 - J Clin Endocrinol Metab. 2000 Sep;85(9):3313-8 9360508 - J Clin Endocrinol Metab. 1997 Nov;82(11):3570-3 11566957 - Hypertension. 2001 Sep;38(3 Pt 2):688-91 11595502 - J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29 7792815 - Steroids. 1995 Jan;60(1):48-51 10843166 - J Clin Endocrinol Metab. 2000 May;85(5):1863-7 10946893 - J Clin Endocrinol Metab. 2000 Aug;85(8):2854-9 10599685 - J Clin Endocrinol Metab. 1999 Dec;84(12):4341-4 10852446 - J Clin Endocrinol Metab. 2000 Jun;85(6):2160-6 |
References_xml | – volume: 38 start-page: 688 year: 2001 ident: 10.3346/jkms.2010.25.9.1379_ref3 publication-title: Hypertension doi: 10.1161/01.HYP.38.3.688 – volume: 138 start-page: 715 year: 2001 ident: 10.3346/jkms.2010.25.9.1379_ref17 publication-title: J Pediatr doi: 10.1067/mpd.2001.112648 – volume: 85 start-page: 1863 year: 2000 ident: 10.3346/jkms.2010.25.9.1379_ref4 publication-title: J Clin Endocrinol Metab – volume: 207 start-page: 565 year: 1995 ident: 10.3346/jkms.2010.25.9.1379_ref5 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1995.1225 – volume: 48 start-page: 682 year: 2004 ident: 10.3346/jkms.2010.25.9.1379_ref8 publication-title: Arq Bras Endocrinol Metabol doi: 10.1590/S0004-27302004000500014 – volume: 355 start-page: 262 year: 1992 ident: 10.3346/jkms.2010.25.9.1379_ref2 publication-title: Nature doi: 10.1038/355262a0 – volume: 82 start-page: 3570 year: 1997 ident: 10.3346/jkms.2010.25.9.1379_ref10 publication-title: J Clin Endocrinol Metab – volume: 78 start-page: 215 year: 2001 ident: 10.3346/jkms.2010.25.9.1379_ref11 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/S0960-0760(01)00097-8 – volume: 60 start-page: 48 year: 1995 ident: 10.3346/jkms.2010.25.9.1379_ref14 publication-title: Steroids doi: 10.1016/0039-128X(94)00010-A – volume: 85 start-page: 3313 year: 2000 ident: 10.3346/jkms.2010.25.9.1379_ref15 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.85.9.6834 – volume: 28 start-page: 1087 year: 2001 ident: 10.3346/jkms.2010.25.9.1379_ref12 publication-title: Clin Exp Pharmacol Physiol doi: 10.1046/j.1440-1681.2001.03574.x – volume: 85 start-page: 2160 year: 2000 ident: 10.3346/jkms.2010.25.9.1379_ref13 publication-title: J Clin Endocrinol Metab – volume: 95 start-page: 1109 year: 1966 ident: 10.3346/jkms.2010.25.9.1379_ref1 publication-title: Can Med Assoc J – volume: 19 start-page: 325 year: 2005 ident: 10.3346/jkms.2010.25.9.1379_ref7 publication-title: J Hum Hypertens doi: 10.1038/sj.jhh.1001821 – volume: 84 start-page: 4341 year: 1999 ident: 10.3346/jkms.2010.25.9.1379_ref16 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.84.12.6256 – volume: 85 start-page: 2854 year: 2000 ident: 10.3346/jkms.2010.25.9.1379_ref6 publication-title: J Clin Endocrinol Metab – volume: 15 start-page: 173 year: 2001 ident: 10.3346/jkms.2010.25.9.1379_ref9 publication-title: J Hum Hypertens doi: 10.1038/sj.jhh.1001152 – reference: 10946893 - J Clin Endocrinol Metab. 2000 Aug;85(8):2854-9 – reference: 4288576 - Can Med Assoc J. 1966 Nov 26;95(22):1109-19 – reference: 11317201 - J Hum Hypertens. 2001 Mar;15(3):173-6 – reference: 10999827 - J Clin Endocrinol Metab. 2000 Sep;85(9):3313-8 – reference: 7864844 - Biochem Biophys Res Commun. 1995 Feb 15;207(2):565-71 – reference: 15761539 - Arq Bras Endocrinol Metabol. 2004 Oct;48(5):682-6 – reference: 11566957 - Hypertension. 2001 Sep;38(3 Pt 2):688-91 – reference: 10852446 - J Clin Endocrinol Metab. 2000 Jun;85(6):2160-6 – reference: 7792815 - Steroids. 1995 Jan;60(1):48-51 – reference: 9360508 - J Clin Endocrinol Metab. 1997 Nov;82(11):3570-3 – reference: 11595502 - J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29 – reference: 1731223 - Nature. 1992 Jan 16;355(6357):262-5 – reference: 10599685 - J Clin Endocrinol Metab. 1999 Dec;84(12):4341-4 – reference: 11343049 - J Pediatr. 2001 May;138(5):715-20 – reference: 15660117 - J Hum Hypertens. 2005 Apr;19(4):325-7 – reference: 10843166 - J Clin Endocrinol Metab. 2000 May;85(5):1863-7 – reference: 11903322 - Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1087-90 |
SSID | ssj0025523 |
Score | 1.9324646 |
Snippet | Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1379 |
SubjectTerms | Adolescent Aldosterone - blood Asian Continental Ancestry Group - genetics Case Report Cytochrome P-450 CYP11B2 - genetics Dexamethasone - therapeutic use Family Female Glucocorticoids - therapeutic use Humans Hyperaldosteronism - diagnosis Hyperaldosteronism - drug therapy Hyperaldosteronism - genetics Hypertension - etiology Magnetic Resonance Angiography Male Middle Aged Renin - blood Renin - metabolism Republic of Korea Sequence Analysis, DNA Steroid 11-beta-Hydroxylase - genetics Young Adult 의학일반 |
Title | Genetic Analyses of the Chimeric CYP11B1 / CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20808686 https://www.proquest.com/docview/753999604 https://pubmed.ncbi.nlm.nih.gov/PMC2923798 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001469820 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Korean Medical Science, 2010, 25(9), 142, pp.1379-1383 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELbaIiEuiDfhsTISR7IkfiTxASGoqFqqRRxYqZwsO7ZptNsENrsS_Htm4uyqRS0nH_ySPGP5m4e_IeS1QFayUsFNUyKkQsYkAJNiBMvW3mVhYGKafSmO5-LzmTzbI9uqqOMB9teadlhPar5aTn__-vMeLvw7tDg5RigXF31M0mJyqqY5L9U-uQVPU4HW2EzswgoAnxmP1EM3TURyYABRVYGfqy-9VPvtKlwHQv_Npbz0OB3dI3dHVEk_RDW4T_Z8-4Dcno1x84dkg-zS0EfNwEHie9oFCtCP1ufNELKhh9-_5vnH_G1sGQW98rRpqaGnHeDKlkZPCEW_LR3y3MFshRW7xqXoYkQf7tJTs3T4awQJd_uLR2R-9Onb4XE6FlxIa4BJ69Ri6RHjKhc8oJzC8Moqntk8V85KVxTGqUzUeRBC-FAbrhxzzGeWKQs4yxv-mBy0XeufEiqdlKXx3MtgBcvrymeZ82WAK89M4CIhbHu4uh7ZyLEoxlKDVYLC0SgcjcLRTGqlUTgJebOb9DOScfx_-CuQml7UjUYSbWx_dHqx0mAqnGhZCoCfCaFbmWq4WBgtMa3vNr0ukbMXqWsS8iSKeLfnVkMSUl4R_m4Abne1p23OB-5uBoC6VNWzG9d8Tu7EBAVMY3tBDtarjX8JuGdtJ4D4T04ng9dgMuj1X2dDAQM |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+analyses+of+the+chimeric+CYP11B1%2FCYP11B2+gene+in+a+Korean+family+with+glucocorticoid-remediable+aldosteronism&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Lee%2C+Ihn+Suk&rft.au=Kim%2C+Seul+Young&rft.au=Jang%2C+Hye+Won&rft.au=Kim%2C+Min+Kyeong&rft.date=2010-09-01&rft.eissn=1598-6357&rft.volume=25&rft.issue=9&rft.spage=1379&rft_id=info:doi/10.3346%2Fjkms.2010.25.9.1379&rft_id=info%3Apmid%2F20808686&rft.externalDocID=20808686 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon |